5 research outputs found

    Do Injection Drug Networks Inform HIV Prevention Service Utilization among People Who Inject Drugs in India? Exploring the Roles of Network Size, Position & Peer Behaviors

    No full text
    Background: India has one of the largest populations of people who inject drugs (PWID), and injection drug use continues to drive new HIV infections. Despite availability of efficacious HIV-prevention services—HIV testing, medication for opioid use disorder (MOUD), and syringe services—evidence suggests that service uptake is suboptimal. While HIV prevention strategies for PWID traditionally have focused on individual-level risk, injection drug use occurs in the context of injection drug networks. This dissertation aims to characterize the role of injection drug networks (network size, position, and peer behaviors) on the HIV prevention behaviors of PWID in India. Methods: First, we utilized data from over 5,278 HIV-negative and HIV-positive yet undiagnosed PWID collected via respondent driven sampling across eight Indian sites (2016/17), to examine the association between self-reported injection network size in the prior 30 days—(a) number of network peers seen and (b) number of injection partners—and uptake of HIV testing, MOUD and syringe services. We additionally ascertained longitudinal uptake services through biometrically matching participants to programmatic clinic-based data. Second, we used baseline data from a longitudinal sociometric injection drug network of 2,512 PWID in New Delhi, India, enumerated via biometric linkage (2017-2020). We classified PWID network position as central vs. peripheral and assessed HIV testing, MOUD, and syringe service utilization as a function of network position. Ensuing analyses attempted to identify biologic, behavioral, and demographic predictors of network centrality. Finally, the sociometric data were used to evaluate PWID engagement in HIV prevention services as a function of service engagement, HIV/HCV status, or injection drug use behaviors of direct injection partners and socially proximal injection peers (≤3 links from each participant). Results: PWID engagement in HIV prevention services was low across all settings. In the multi-city analysis, we observed increased engagement in HIV testing, MOUD, and syringe services among PWID who reported knowing and seeing more network peers. Contrastingly, we found decreased HIV testing and MOUD engagement, yet increased syringe service utilization, among PWID with more injection partners. In the New Delhi sociometric cohort, using betweenness centrality to parameterize central vs. peripheral network position, baseline data indicated that central PWID exhibited increased HIV prevention service engagement, yet reported riskier injection practices. Although findings were consistent across multiple definitions of centrality, we were unable to accurately predict central vs. peripheral network position with available individual-level demographic and behavioral data. Finally, we found strong associative relationships between individual HIV prevention service utilization and the health or risk-taking behaviors of direct and socially proximal injection peers. Conclusions: To date, HIV prevention strategies for PWID in India have focused on maximizing access and utilization of HIV testing and harm reduction services for the individual. These data suggest that injection drug network size, position, and peer behaviors are important components of individual-level HIV prevention service utilization. Findings of this dissertation point to the possibility of leveraging structural and interpersonal relationships among PWID drug networks to promote HIV prevention behaviors in this vulnerable population

    Do Injection Drug Networks Inform HIV Prevention Service Utilization among People Who Inject Drugs in India? Exploring the Roles of Network Size, Position & Peer Behaviors

    No full text
    Background: India has one of the largest populations of people who inject drugs (PWID), and injection drug use continues to drive new HIV infections. Despite availability of efficacious HIV-prevention services—HIV testing, medication for opioid use disorder (MOUD), and syringe services—evidence suggests that service uptake is suboptimal. While HIV prevention strategies for PWID traditionally have focused on individual-level risk, injection drug use occurs in the context of injection drug networks. This dissertation aims to characterize the role of injection drug networks (network size, position, and peer behaviors) on the HIV prevention behaviors of PWID in India. Methods: First, we utilized data from over 5,278 HIV-negative and HIV-positive yet undiagnosed PWID collected via respondent driven sampling across eight Indian sites (2016/17), to examine the association between self-reported injection network size in the prior 30 days—(a) number of network peers seen and (b) number of injection partners—and uptake of HIV testing, MOUD and syringe services. We additionally ascertained longitudinal uptake services through biometrically matching participants to programmatic clinic-based data. Second, we used baseline data from a longitudinal sociometric injection drug network of 2,512 PWID in New Delhi, India, enumerated via biometric linkage (2017-2020). We classified PWID network position as central vs. peripheral and assessed HIV testing, MOUD, and syringe service utilization as a function of network position. Ensuing analyses attempted to identify biologic, behavioral, and demographic predictors of network centrality. Finally, the sociometric data were used to evaluate PWID engagement in HIV prevention services as a function of service engagement, HIV/HCV status, or injection drug use behaviors of direct injection partners and socially proximal injection peers (≤3 links from each participant). Results: PWID engagement in HIV prevention services was low across all settings. In the multi-city analysis, we observed increased engagement in HIV testing, MOUD, and syringe services among PWID who reported knowing and seeing more network peers. Contrastingly, we found decreased HIV testing and MOUD engagement, yet increased syringe service utilization, among PWID with more injection partners. In the New Delhi sociometric cohort, using betweenness centrality to parameterize central vs. peripheral network position, baseline data indicated that central PWID exhibited increased HIV prevention service engagement, yet reported riskier injection practices. Although findings were consistent across multiple definitions of centrality, we were unable to accurately predict central vs. peripheral network position with available individual-level demographic and behavioral data. Finally, we found strong associative relationships between individual HIV prevention service utilization and the health or risk-taking behaviors of direct and socially proximal injection peers. Conclusions: To date, HIV prevention strategies for PWID in India have focused on maximizing access and utilization of HIV testing and harm reduction services for the individual. These data suggest that injection drug network size, position, and peer behaviors are important components of individual-level HIV prevention service utilization. Findings of this dissertation point to the possibility of leveraging structural and interpersonal relationships among PWID drug networks to promote HIV prevention behaviors in this vulnerable population

    Metadata record for: HIT-COVID, a global database tracking public health interventions to COVID-19

    No full text
    This dataset contains key characteristics about the data described in the Data Descriptor HIT-COVID, a global database tracking public health interventions to COVID-19. Contents: 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON forma
    corecore